1. PPCA Inc. holds an allocation of 1.4% in $BMY in his Centric Core Investment Portfolio

  2. Jesse Barkasy sold $BMY and now holds an allocation of 0.0% in their Trend Following Investment Portfolio

  3. Jesse Barkasy bought $BMY and now holds an allocation of 14.5% in their Trend Following Investment Portfolio

  4. Jesse Barkasy bought $BMY and now holds an allocation of 4.8% in their Trend Following Investment Portfolio

  5. Atlas Capital holds an allocation of -2.4% in $BMY in his 100-30 Portfolio Investment Portfolio

  6. Deals of the Day: $BABA Spends $380 Million on Stake in China’s #EnlightMedia, $TM, $BMY http://thudderwicks.com/2015/03/macquarie-stallergenes-fig-icbpi-uber-dvr-bobe-baba-tm-bmy-genfit-ibm-bax-areva-xom-avgo-fsl/

  7. Bristol-Myers Squibb Enters Drug Licensing Deal With Danish Biotechnology Firm https://myaccount.nytimes.com/auth/login?URI=http%3A%2F%2Fwww.nytimes.com%2F2015%2F03%2F05%2Fbusiness%2Fdealbook%2Fbristol-myers-squibb-enters-drug-licensing-deal-with-danish-biotechnology-firm.html%3Fsmid%3Dtw-share%26_r%3D5&REFUSE_COOKIE_ERROR=SHOW_ERROR $BMY

  8. $BMY Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC(R), a Prostate-Specific http://www.finances.com/company-news/71941-bristol-myers-squibb-signs-exclusive-agreement-with-bavarian-nordic-for-prostvacr-a-prostate-specific-antigen-targeting-cancer-immunotherapy.htm

  9. Bristol-Myers Squibb s $1.6 Billion On New Drug Deals Is Well Spent http://www.trefis.com/stock/bmy/articles/282778/bristol-myers-squibbs-1-6-billion-on-new-drug-deals-is-well-spent/2015-03-03 by Trefis Team $BMY $MRK $PFE

  10. $INTC Joins Forces With Deutsche Telekom- $BMY $SBLK http://www.streetwisereport.com/intel-corporation-nasdaqintc-joins-forces-with-deutsche-telekom-bristol-myers-squibb-company-nysebmy-star-bulk-carriers-corp-nasdaqsblk/110903/

  11. Bristol-Myers Squibb Target of Unusually Large Options Trading $BMY http://www.wkrb13.com/markets/509813/bristol-myers-squibb-target-of-unusually-large-options-trading-bmy/ via @RatingsNetwork 3/2/15

  12. FDA Accepts Bristol-Myers Squibb Co Supplemental Yervoy BLA For Melanoma http://www.bidnessetc.com/35984-fda-accepts-bristolmyers-squibb-co-supplemental-yervoy-bla-for-melanoma/ $BMY

  13. FDA Accepts Bristol-Myers Squibb Co Supplemental Yervoy BLA For Melanoma - http://www.bidnessetc.com/35984-fda-accepts-bristolmyers-squibb-co-supplemental-yervoy-bla-for-melanoma/?utm_content=bufferbece5&utm_medium=social&utm_source=linkedin.com&utm_campaign=buffer $BMY

  14. @upsidetrader i don t know what Bristol Myers is, but i know what BRISTOL MYERRRRRRS is. Cramer s commentary scarred me on that. $BMY

  15. $BMY Bristol-Myers Squibb Announces Dividend http://www.finances.com/company-news/71302-bristol-myers-squibb-announces-dividend-3.htm

  16. @upsidetrader: $BMY not flashy, but slow & steady pays the bills, great setup, looks ready to grind higher http://stocktwits.com/message/33411356

  17. @OpenOutcrier: $BMY popping on volume

  18. $BMY just too much good news for these guys, buy some 70 calls a few months out

  19. $BMY popping on volume

  20. $GILD Since the $BMY HCV cocktail uses Sovaldi. It s not really much in the way of competition, is it...

  21. @jgmke CNBC mentioned last week they will be announcing data soon. If the FDA accepts that will instantly drive down or value. $MRK $BMY

  22. @SeekingAlphaTWITS Bristol Myers HCV Cocktail Has Gilead, AbbVie In Its Crosshairs http://seekingalpha.com/article/2964516 $GILD $ABBV $BMY

  23. Bristol Myers HCV Cocktail Has Gilead, AbbVie In Its Crosshairs http://seekingalpha.com/article/2964516-bristol-myers-hcv-cocktail-has-gilead-abbvie-in-its-crosshairs?source=feed_f$ABBV $BMY $GILD

  24. $BMY appears to have broken out of a consolidation pattern after hitting a 52 week high previously. A move to 65.50 now seems very likely.

  25. $BMY New PDUFA Date 2015-06-22 BRISTOL-MYERS SQUIBB COMPANY Calendar:https://www.fdatracker.com/fda-calendar/ Link:http://www.businesswire.com/news/home/20150227005922/en/U.S.-Food-Drug-Administration-Accepts-Biologics-Licensing